You searched for "periorbital"
What's trending Oct/Nov 2024
3 October 2024
| Amit Dhalla
|
EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #PommelHorseGuy #Olympics The Paris Olympics have been such a delight this year, from incredible physical feats to touching competitor comradery, I...
DMEK vs. UT-DSAEK: has the debate been finally concluded?
In recent years the surgical treatment of corneal endothelial dystrophy has progressed tremendously. Descemet’s membrane endothelial keratoplasty (DMEK) is the newest iteration in the line of rapid surgical advances that has taken place. However, the previously accepted gold standard prior...Ophthalmology in a War Zone: an interview with Dr Volodymyr Melnyk
It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...Eyecare education in times of COVID-19
4 February 2021
| Martin Anderson, Karsten Paust, Andrew Blaikie
|
EYE - General
A collaboration between the German Committee for the Prevention of Blindness (DKVB), Rukwa regional government in Tanzania and the University of St Andrews Global Health Team successfully delivered a hybrid teaching programme for ophthalmic nurses in Sumbawanga, south west Tanzania,...
Diabetes macular oedema in pregnancy self-resolving postpartum
1 October 2021
| Rajesh Deshmukh, Antony Raharja, Li Teng Kok
|
EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
*Equally contributing co-first authors. Diabetic macular oedema (DMO) is a common clinical presentation to ophthalmology clinics. Ample evidence exists for management of DMO in non-pregnant patients. However, there is a paucity of evidence on the optimal management of DMO in...
Retinopathy of prematurity treatment in the South West of England: long-term outcomes 1997-2008
1 December 2014
| Anna Pang, Jonathan Park, Anthony Quinn, Roland Ling
|
EYE - Vitreo-Retinal
Retinopathy of prematurity (ROP) is a condition that affects the developing retinal vascular system of pre-term babies. If left untreated, ROP can lead to severe visual impairment. The severe visual impairment caused by untreated ROP can be prevented by screening...
Update on emerging therapies for age-related macular degeneration
4 December 2023
| Rod McNeil
|
EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...
Surgical options for the treatment of hyperopia
The modern refractive surgeon has a variety of options available to treat patients with hyperopia who wish to be independent of spectacles and contact lenses. Unlike in low myopia where presbyopic patients may have the ability to see well for...Eye Capacity: clinical need should drive ophthalmic service provision
1 February 2014
| Rod McNeil
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...
Considerations in the management of retinal disorders
1 October 2017
| Rod McNeil
|
EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...
